INTECH Investment Management’s Ocular Therapeutix OCUL Stock Holding History

INTECH Investment Management’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$489K	Sell	49,834 -26,009	-34%	-$236K	﹤0.01%	1356
2026 Q1	$642K	Sell	75,843 -20,189	-21%	-$192K	0.01%	1221
2025 Q4	$1.17M	Buy	96,032 +17,611	+22%	+$214K	0.01%	1046
2025 Q3	$917K	Sell	78,421 -12,815	-14%	-$153K	0.01%	1219
2025 Q2	$847K	Sell	91,236 -22,361	-20%	-$175K	0.01%	1295
2025 Q1	$833K	Buy	113,597 +14,165	+14%	+$109K	0.01%	1313
2024 Q4	$849K	Buy	99,432 +50,949	+105%	+$497K	0.01%	1253
2024 Q3	$422K	Buy	+48,483	New	+$400K	﹤0.01%	1322

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

INTECH Investment Management's OCUL Position: Q2 2026 in Review

INTECH Investment Management reduced its Ocular Therapeutix (OCUL) stake by 34% in Q2 2026, selling an estimated $236K and leaving 49,834 shares worth $489K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

INTECH Investment Management first reported a position in OCUL in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.17M in Q4 2025. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

INTECH Investment Management held 49,834 shares of Ocular Therapeutix worth $489K as of Q2 2026.
INTECH Investment Management sold 26,009 Ocular Therapeutix shares in Q2 2026, an estimated $236K.
Ocular Therapeutix made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1356 holding.
INTECH Investment Management first reported a position in Ocular Therapeutix in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Ocular Therapeutix position peaked at $1.17M in Q4 2025.
262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.